Charles Hsu is an associate practicing intellectual property law with a primary focus on patent litigation. Mr. Hsu represents technology and pharmaceutical companies in IP litigation lawsuits, as both plaintiffs and defendants. He has been involved in a broad spectrum of cases involving the life science and electrical engineering fields, including areas such as antibodies, peptides, biologics, small-molecule therapeutics, medical devices, and telecommunications. Mr. Hsu’s experience spans all stages of litigation in both the District Courts and the Patent Trial and Appeal Board (PTAB), including pre-suit investigation, fact and expert discovery, Markman, trial, and appeal. Mr. Hsu has also demonstrated his oral advocacy skills by presenting arguments at Markman and before the PTAB. Mr. Hsu maintains an active pro bono practice at Dechert, which includes representation in immigration, employment, and intellectual property matters.
Mr. Hsu earned his Juris Doctor from Berkeley Law School in 2019, where he was an Associate Editor of the California Law Review. While in law school, Mr. Hsu also advised start-up companies on intellectual property matters, including drafting patent applications and conducting freedom to operate analysis for a biotechnology company.
-
- University of California, Santa Cruz, B.S., B.A., Molecular, Cellular, and Developmental Biology; Economics, 2014
- University of California, Berkeley, School of Law, J.D., 2019, Associate Editor, California Law Review, Law and Technology Certificate
-
- California
- United States District Court for the Northern District of California
- United States Patent and Trademark Office
-
- Mandarin